Literature DB >> 11500339

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

S Harbarth1, K Holeckova, C Froidevaux, D Pittet, B Ricou, G E Grau, L Vadas, J Pugin.   

Abstract

To assess the diagnostic value of procalcitonin (PCT), interleukin (IL)-6, IL-8, and standard measurements in identifying critically ill patients with sepsis, we performed prospective measurements in 78 consecutive patients admitted with acute systemic inflammatory response syndrome (SIRS) and suspected infection. We estimated the relevance of the different parameters by using multivariable regression modeling, likelihood-ratio tests, and area under the receiver operating characteristic curves (AUC). The final diagnosis was SIRS in 18 patients, sepsis in 14, severe sepsis in 21, and septic shock in 25. PCT yielded the highest discriminative value, with an AUC of 0.92 (CI, 0.85 to 1.0), followed by IL-6 (0.75; CI, 0.63 to 0.87), and IL-8 (0.71; CI, 0.59 to 0.83; p < 0.001). At a cutoff of 1.1 ng/ml, PCT yielded a sensitivity of 97% and a specificity of 78% to differentiate patients with SIRS from those with sepsis-related conditions. Median PCT concentrations on admission (ng/ ml, range) were 0.6 (0 to 5.3) for SIRS; 3.5 (0.4 to 6.7) for sepsis; 6.2 (2.2 to 85) for severe sepsis; and 21.3 (1.2 to 654) for septic shock (p < 0.001). The addition of PCT to a model based solely on standard indicators improved the predictive power of detecting sepsis (likelihood ratio test; p = 0.001) and increased the AUC value for the routine value-based model from 0.77 (CI, 0.64 to 0.89) to 0.94 (CI, 0.89 to 0.99; p = 0.002). In contrast, no additive effect was seen for IL-6 (p = 0.56) or IL-8 (p = 0.14). Elevated PCT concentrations appear to be a promising indicator of sepsis in newly admitted, critically ill patients capable of complementing clinical signs and routine laboratory parameters suggestive of severe infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500339     DOI: 10.1164/ajrccm.164.3.2009052

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  220 in total

1.  Biomarkers of sepsis: is procalcitonin ready for prime time?

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2002-09       Impact factor: 17.440

2.  Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study.

Authors:  Wei Li; Linying Guo; Hongri Li; Chunrong Sun; Xiaodai Cui; Guowei Song; Jianhua Wang; Qi Zhang
Journal:  Eur J Pediatr       Date:  2014-11-01       Impact factor: 3.183

3.  Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP).

Authors:  Y X Liew; M P Chlebicki; W Lee; L Y Hsu; A L Kwa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-29       Impact factor: 3.267

Review 4.  An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients.

Authors:  Dimitrios K Matthaiou; Georgia Ntani; Marina Kontogiorgi; Garyfallia Poulakou; Apostolos Armaganidis; George Dimopoulos
Journal:  Intensive Care Med       Date:  2012-04-27       Impact factor: 17.440

Review 5.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

6.  Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis.

Authors:  Bettina Schrag; Katia Iglesias; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-03-29       Impact factor: 2.686

Review 7.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage.

Authors:  Emir Festic; Jason Siegel; Matthew Stritt; William D Freeman
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

10.  Immature platelet fraction in predicting sepsis in critically ill patients.

Authors:  Roberto Alberto De Blasi; Patrizia Cardelli; Alessandro Costante; Micol Sandri; Marco Mercieri; Roberto Arcioni
Journal:  Intensive Care Med       Date:  2012-10-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.